Debjit Chattopadhyay Maintained (ZYME) at Strong Buy with Decreased Target to $54 on, Jul 9th, 2020
Debjit has made no other calls on ZYME in the last 4 months.
There is 1 other peer that has a rating on ZYME. Out of the 1 peers that are also analyzing ZYME, 0 agree with Debjit's Rating of Hold.
This is the rating of the analyst that currently disagrees with Debjit
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $50 on, Tuesday, June 2nd, 2020
on: Mon, Jul 06th 2020
by: WOPRAI
Nigel Dally Maintained (BHF) at Hold with Increased Target to $28 on, Jul 6th, 2020
on: Thu, Jul 02nd 2020
by: WOPRAI
John Barnidge Maintained (BHF) at Hold with Decreased Target to $28 on, Jul 2nd, 2020
on: Thu, Jul 02nd 2020
by: WOPRAI
Richard Cathcart Upgraded (ARCO) to Buy and Increased Target to $5.84 on, Jul 2nd, 2020
on: Thu, Jul 02nd 2020
by: WOPRAI
Daina Graybosch Maintained (BNTX) at Hold with Increased Target to $42 on, Jul 2nd, 2020
on: Tue, Jun 30th 2020
by: WOPRAI
Yigal Nochomovitz Maintained (APLS) at Strong Buy with Decreased Target to $54 on, Jun 30th, 2020
on: Tue, Jun 23rd 2020
by: WOPRAI
Buck Horne Reiterated (AMH) at Strong Buy with Increased Target to $34 on, Jun 23rd, 2020
on: Fri, Jun 12th 2020
by: WOPRAI
Robert Burns Maintained (ALLO) at Strong Buy with Decreased Target to $49 on, Jun 12th, 2020
on: Tue, Jun 02nd 2020
by: WOPRAI
Yigal Nochomovitz Maintained (ZYME) at Strong Buy with Increased Target to $50 on, Jun 2nd, 2020
on: Mon, May 11th 2020
by: WOPRAI
Raghuram Selvaraju Reiterated (SPRO) at Strong Buy with Increased Target to $28 on, May 11th, 2020
on: Tue, Dec 17th 2019
by: WOPRAI
Liana Moussatos Maintained (AQST) at Buy with Decreased Target to $34 on, Dec 17th, 2019
on: Mon, Nov 25th 2019
by: WOPRAI
Debjit Chattopadhyay Initiated (ZYME) at Strong Buy and Held Target at $65 on, Nov 25th, 2019
on: Tue, Jul 21st 2015
by: WOPRAI
Robert Ohmes Downgraded (UNFI) to Sell and Decreased Target to $50 on, Jul 21st, 2015